Hedge fund Paulson & Co declares 6.3 percent stake in Valeant: Reuters

New York-based hedge fund Paulson & Co has declared a 6.3 percent stake in Canada's Valeant Pharmaceuticals International Inc, Reuters reported. Paulson, Valeant's biggest stakeholder, had a 5.68 percent stake in the company as of March 31, according to Thomson Reuters data. Last week, billionaire investor John Paulson joined the ailing drug company's board as it restructures to repay debt.

DealsCanadaNorth AmericaBriefs